A B S T R A C T A technique is described for the measurement of muscle capillary basement membranes by electron microscopic examination of needle biopsies of the quadriceps muscle. With this procedure it has been possible to obtain an objective evaluation of the significance of capillary basement membrane hypertrophy in diabetic mi- than genetic diabetes only infrequently show basement membrane hypertrophy. These results indicate that thickening of the muscle capillary basement membranes is a characteristic of genetic diabetes mellitus, and further, that the hyperglycemia of diabetes is probably not the factor responsible for the microangiopathy characteristic of diabetes mellitus. Finally, the discovery of thickened capillary basement membranes in prediabetic patients suggests that basement membrane hypertrophy is a relatively early lesion of the diabetic syndrome and provides further support for the conclusion that this vascular defect is independent of carbohydrate derangements of diabetes mellitus.
A B S T R A C T A technique is described for the measurement of muscle capillary basement membranes by electron microscopic examination of needle biopsies of the quadriceps muscle. With this procedure it has been possible to obtain an objective evaluation of the significance of capillary basement membrane hypertrophy in diabetic microangiopathy. The results *of such studies of muscle capillary basement membrane thickness in 50 normal, 51 diabetic, and 30 prediabetic patients have demonstrated the following. First, that the average capillary basement membrane width of diabetic patients is over twice that of normal subjects; moreover, such basement membrane thickening is a very constant finding among overtly diabetic patients, in that approximately 98%o of individual diabetic subjects demonstrated this lesion. The degree of basement membrane thickening in diabetic patients is, however, unrelated to age, weight, severity, or duration of diabetes. Second (1) .
Received for publication 28 December 1967. than genetic diabetes only infrequently show basement membrane hypertrophy.
These results indicate that thickening of the muscle capillary basement membranes is a characteristic of genetic diabetes mellitus, and further, that the hyperglycemia of diabetes is probably not the factor responsible for the microangiopathy characteristic of diabetes mellitus. Finally, the discovery of thickened capillary basement membranes in prediabetic patients suggests that basement membrane hypertrophy is a relatively early lesion of the diabetic syndrome and provides further support for the conclusion that this vascular defect is independent of carbohydrate derangements of diabetes mellitus. INTRODUCTION With the prolongation of life that insulin and subsequently antibiotic therapy have made possible for the diabetic patient, it has become apparent that the vascular complications of diabetes mellitus constitute the major causes of morbidity and death in this disease (2) . Despite increasing interest in these vascular manifestations of diabetes mellitus, neither the basic pathology of diabetic microangiopathy nor the relationship of this vascular disease to the carbohydrate derangements of diabetes has yet been resolved.
A major insight into this problem was provided when Friedenwald (3, 4) , on the basis of light microscopic studies, first suggested that a specific abnormality of the capillary basement membrane
The Journal of Clinical -Investigation Volume 47 1968 might underlie both the renal and the retinal complications of diabetes. This suggestion was strongly supported by the electron microscopic observations of Bergstrand and Bucht (5) , and of Farquhar, Hopper, and Moon (6) , each of whom independently provided evidence that an accumulation of basement membrane or of basement membrane-like material in the capillaries of the glomerulus may represent the earliest and perhaps the underlying vascular abnormality of diabetic renal disease. In subsequent years, hypertrophy of the capillary basement membranes has also been observed in a number of other diabetic tissues, including retina (7), skin (8, 9) , nerve (10) , muscle (7, (11) (12) (13) (14) , and placenta (15) . On the basis of these observations several investigators have raised the possibility that widespread thickening of the capillary basement membranes may in fact represent the single lesion responsible for all of the vascular complications of diabetes (7, 11, 15) . Despite its potential importance, it should be noted that such a concept of diabetic vascular disease has not to date been supported by any systematic study either of the actual incidence or of the degree of basement membrane thickening in diabetic patients. Moreover, in recent years several reports using objective measurements of capillary basement membrane width in kidney (16, 17) , muscle (18) , and skin (19) have raised serious doubts as to the validity of the earlier, more subjective impressions that basement membrane hypertrophy represents the underlying lesion of diabetic microangiopathy.
Finally, there are as yet few data that can serve to resolve the important question of whether capillary basement membrane thickening, even when present, is the consequence of the carbohydrate abnormalities of diabetes, or whether on the other hand such basement membrane hypertrophy might represent a primary lesion of diabetes mellitus.
The present study has attempted to answer these questions by employing a simple needle biopsy technique that permits examination of muscle capillaries in large numbers of patients on an outpatient basis. This technique, used in connection with an objective and reproducible quantitative measurement of capillary basement membrane width, has made it possible to evaluate the significance of muscle capillary basement membrane thickness in normal, diabetic, and genetically prediabetic subjects.
An examination of capillary basement membrane width in such patients has demonstrated first, that basement membrane thickening is a very constant finding in the diabetic muscle capillary, the lesion being present in 98%o of patients with diabetes mellitus. The degree of this basement membrane hypertrophy, however, bears little relationship to the age or weight of the diabetic patient or to the duration or severity of the carbohydrate abnormalities of the diabetes. Second, in contrast to the findings in genetically diabetic patients, severe hyperglycemia of nondiabetic origin is rarely accompanied by basement membrane thickening. Finally, significant basement membrane hypertrophy could be demonstrated in approximately one-half of a series of prediabetic patients with no detectable evidence of carbohydrate abnormalities. These latter two findings taken together strongly suggest that thickening of capillary basement membranes, and hence the microangiopathy of diabetes, are not the result of the hyperglycemia of diabetes mellitus, but may represent a distinct lesion of the diabetic syndrome.
METHODS
Biopsy technique. Except where specifically noted, muscle biopsies throughout this study were obtained from the lateral aspect of the quadriceps muscle at a point midway between the knee and the hip. After infiltration of the skin, underlying tissue, and muscle with 1% Xylocaine (Astra Pharmaceutical Products, Inc., Worchester, Mass.), a 10-20 mg specimen of muscle was obtained with a modified Franklin-Silverman biopsy needle. The most satisfactory results were noted with a needle in which a plug, 2 mm in length, was silversoldered into the tip of the needle (Fig. 1 ).1 With this needle, biopsies could be readily obtained as an outpatient procedure with minimal discomfort to the patient. The only complications encountered in the biopsies performed to date at this site have consisted of three hematomas, two of which were sufficiently severe to cause discomfort for about 1 wk. An identical technique was employed to obtain biopsies of deltoid and gastrocnemius muscles and adipose tissue. The site of the adipose tissue biopsies was the lateral aspect of the thigh. Renal tissue was obtained by percutaneous biopsy 2 with a Vim Silverman needle.
1 These modifications were made for us by the Travenol Laboratories, Morton Grove, Ill., and are designated as Vim No. VT131 Silverman Biopsy Needle with modified cannula for cutting and holding specimen. Electron microscopy and measuremzent of capillary basement membrane width. All muscle biopsies were obtained in duplicate and fixed in Palade's buffered osmium tetroxide fixative (20) . After 60 min of fixation, the specimens were placed in 3.7% formaldehyde for 30 min and then were dehydrated successively through 70%, 95%, and 100% ethanol, and two changes of propylene oxide. with a ruler at the 20 points of intersection of these lines with the basement membrane (Fig. 2) . Measurements were not taken when a radiating line intersected a pericyte because such pericytes are typically surrounded by basement membrane, and as a result the total width of the basement membrane at these sites tends to be twice that seen at other locations. If for any reason at least 10 measurements could not be obtained from a given photograph, the picture was discarded, and an additional capillary was photographed. In this manner between 190 and 275 measurements of basement membrane width were obtained from each muscle biopsy, and from these data the average basement membrane width of the 15 vessels was calculated for each patient in the study. An identical procedure was employed to determine basement membrane widths of adipose tissue capillaries and of the capillaries from the peripheral portions of the renal glomeruli. Further justification for this technique and its reproducibility will be presented in the Results section.
Patients. Four groups of patients comprised the subjects of the major portion of the study 3: (a) normal, nondiabetic patients were defined as those subjects having a normal fasting plasma sugar and a normal oral glucose tolerance test, as defined below. In addition, each normal subject was required to have a negative family history for diabetes in a family sufficiently large to give this negative history validity, that is, a total of at least eight brothers, sisters, aunts, and uncles; (b) prediabetic (26) .
RESULTS
Validation of technique of measuring basement membrane width. Since the muscle biopsy technique involves an assessment of basement membrane width in only a small, 10-20 mg sample of muscle, there would appear to be a strong possibility both of sampling errors as well as of technical errors in the procedure. For this reason, preliminary studies were undertaken to determine the validity and the reproducibility of the technique 4 Plasma glucose levels in our laboratory have been found to average 16% higher than whole blood values obtained on the same blood samples.
for measuring basement membrane width. By redirecting the biopsy needle at the time of the initial biopsy, duplicate samples were obtained from the adjacent portions of the quadriceps muscle. In the 15 cases shown in Table I , these duplicate biopsies were fixed, embedded separately, and independent measurements of basement membrane widths were made of each of the two biopsies. As shown in Table I , the average error in measurement of basement membrane thickness of duplicate biopsies is 6.9%. In the case of one patient, B.B., GTT, glucose tolerance test; F, fasting; W, white. * In this subject 12 rather than 15 capillaries were examined. the second biopsy was obtained after an interval of 3 months, despite which the values for basement membrane width agreed within 9%. This relatively small variation between biopsies indicates that both the sampling and measuring techniques were sufficiently reproducible for the purposes of this study.
Another potential source of error in assessing basement membrane width is a possible variation of the calibre of the vessels among the groups of patients being studied. It has, for example, been suggested without supporting data (18) that basement membrane width is proportionate to capillary size, a suggestion that would imply that larger capillaries would have relatively thicker basement membranes. That this is not the case is conclusively demonstrated by the data in Table II, which are  derived from the detailed figures given in Tables   III, IV , and V. In none of the three types of capillaries examined in this study is there a positive correlation between capillary perimeter and basement membrane width. Actually, a small but statistically significant negative correlation between these parameters was noted in the prediabetic Xylocaine for 5 min before fixation. This treatment was found to have no significant influence upon basement membrane width.
Muscle capillary basement membrane width in normal subjects. The initial aim of this study was to define the basement membrane width of muscle capillaries of a nondiabetic population. As noted in the Methods section, this group of subjects was rigorously selected on the basis of a negative family history and a normal oral glucose tolerance curve. Nonetheless, in view of a probable incidence of diabetes mellitus in the general population of approximately 2-6% (27, 28) it can be assumed that despite this screening procedure, a similar percentage of this "normal" group will in fact be genetically diabetic.
Electron micrographs of two typical muscle capillaries from the normal subjects studied are shown in Fig 3 a and b . As indicated, in these electron micrographs the basement membrane of muscle capillaries from nondiabetic patients form single, thin, relatively homogeneous structures completely surrounding the endothelial cell. It should also be noted that in a normal patient the width of the capillary basement membrane is Tables III and VI . The average muscle capillary basement membrane width of the 747 capillaries examined in these nondiabetic subjects was 1080 A, with a standard error of the mean (SE) of 27 A. The values for the basement membrane width of individual capillaries are shown in Fig. 6 and illustrate that the variation within a single subject's capillary basement membrane is relatively small, with only 6%o of individual capillaries having basement membrane widths in excess of 1500 A. Moreover, as indicated by the dotted line in Fig. 6 , if an upper limit of normal for the average basement membrane width based on the point of optimum discrimination is set at 1325 A, 46 of the 50 or 92% of the nondiabetic subjects have average basement membrane widths that fall within this normal range (Table  VII) .
Within the age range of 19-62 yr examined in this study, there is no correlation between the subjects' ages and their muscle capillary basement (Table VIII) . Moreover, as shown in Fig. 9 A, there is also no relationship between the glucose tolerance, i.e. fasting, 1-or 2-hr plasma glucose values, and basement membrane width. On the other hand, a slight but statistically significant (P < 0.05) correlation between body weight and basement membrane width was observed in the nondiabetic subjects (Table  VIII) . In addition, normal men were found to have somewhat thicker basement membrane than women, 1144 A vs. 998 A, P < 0.05 (Table IX) .
Muscle capillary basement membrane width in diabetic subjects. Typical electron micrographs of two diabetic capillaries are presented in Fig. 4 a and b. It is readily apparent from these examples that marked basement membrane hypertrophy can be subjectively recognized in many diabetic muscle capillaries. The density of the diabetic basement membrane does not differ detectably from that of normal capillaries nor can any difference in internal structure of the membrane be detected. Finally, the endothelial cells surrounding the capillaries of diabetic patients show no obvious alterations from those of normal subjects.
The measurements of basement membrane width presented in Tables IV and VI, and Fig. 7 , clearly demonstrate that the muscle capillary basement membranes of the 51 diabetic patients are in fact much thicker than those of the nondiabetic subjects, the average basement membrane width of the 765 diabetic capillaries being 2403 A (SE + 119), a value that is over twice that of the normal subjects of 1080 A. As indicated in summary Table VI, the difference between the means of the normal and diabetic basement membrane widths is significant at the < 0.01 level.
The incidence of capillary basement membrane hypertrophy in the diabetic group is presented in Table VII. Utilizing the upper limit of normal of 1325 A, as shown in Fig. 7 , all but one of the 51 diabetic patients demonstrated capillary basement membrane thickening. These results therefore demonstrate not only that basement membrane hypertrophy of muscle capillaries can readily be documented on the basis of the average widths of large numbers of diabetic capillaries, but that in addition this lesion is an almost constant feature of individual cases of diabetes.
Relation of basement membrane width to age, sex, weight, duration, and severity of diabetes. Tables III and  IV , the average age of the diabetic patients in this study was somewhat greater than that of normal subjects. However, in view of the lack of an effect of age on basement membrane width in either normal or diabetic groups, this factor could obviously not have influenced the marked differences in basement membrane width that exist between the two groups. As the data in were subdivided into those whose diabetes could be controlled with either diet alone or with oral hypoglycemic agents, and those who require insulin to maintain reasonable control of their diabetes. As shown in Table X , there is no relationship between the degree of basement membrane hypertrophy and the severity of the carbohydrate disturbance of diabetes.
Finally, a similar analysis of diabetic patients who had developed their disease before age 21 as compared to those with a later onset of diabetes again demonstrates no significant difference in the degree of basement membrane hypertrophy between the two groups (Table XI) . These results therefore indicate that "juvenile" and "adult" onset diabetics have equally severe thickening of muscle capillary basement membrane, a finding that leads to the general conclusion that neither severity of carbohydrate disorder nor age of onset influences the severity of the muscle capillary lesion of the diabetic.
Basement membrane width in patients with nondiabetic hyperglycemia. In summary, these findings would strongly suggest that in man, hyperglycemia, even though severe and of long duration, does not cause basement membrane thickening in the absence of genetic diabetes mellitus.
Basement membrane width in hyperglycemic animals. The inability of hyperglycemia to produce muscle capillary basement membrane hypertrophy has been confirmed in several animal models. Spontaneous hyperglycemia occurs in inbred strains of Chinese hamsters (30, 31) . How- 10 ).
Representative examples of capillaries from these prediabetic subjects are shown in Fig. 5 a and b , and, as is evident from these electron micrographs, the basement membranes of such capillaries appear thicker than those from nondiabetic patients (Fig. 3 a and b) . This impression is confirmed by the quantitative data presented in Tables V and VI, and illustrated in Fig. 8 . The average basement membrane width of the prediabetic group is 1373 A (SE + 44), a figure that is significantly greater than that of the normal subjects. The actual incidence of basement membrane hypertrophy within the prediabetic group bears out this conclusion: that of the 30 prediabetic patients, 16 or 53% were found to have demonstrable basement membrane hypertrophy at the time of the study (Table VII) glucose metabolism in the individual who is destined to become diabetic. Relationship of basement membrane width to glucose tolerance in prediabetic subjects. As noted above, the prediabetic patients in this study were found to have glucose tolerance tests that did not differ significantly from those of the normal group. Nonetheless, if subtle abnormalities in carbohydrate metabolism were responsible for basement membrane thickening in diabetes mellitus, it is still possible that, despite the normal glucose tolerance tests of the prediabetic group, those prediabetic patients with relatively poorer glucose tolerance might show the thicker basement membranes. The regression analyses in Fig.  9 A and B in fact demonstrate however that within the prediabetic subj ects, there is no significant relationship between fasting, 1-hr, or 2-hr glucose levels, and basement membrane width. In other words, thickening of capillary basement membranes was as frequently observed in those prediabetic patients with flat glucose tolerance tests as in those with tolerance curves that are in the upper range of normal.
Two other variables could conceivably have played roles in yielding the increased basement membrane thickness noted in the prediabetic group. As noted earlier, a small but significant difference in basement membrane width was observed between men and women in the normal group. As shown in Table IX Moreover, since normal men have somewhat thicker basement membranes than do normal women, the greater proportion of women in the prediabetic group would, if anything, decrease the difference in basement membrane width between the two populations. Finally, when analyzed separately by sex, the difference between the normal and prediabetic groups remains highly significant for both sexes.
A correlation between weight and basement width was observed both in the normal and in the prediabetic groups, Table VIII , and conceivably therefore, differences in weights between the two groups might have influenced the average basement membrane widths. To eliminate this possibility, the data were analyzed in selected groups of normal and prediabetic subjects that were equalized for weight and for weight/height. Even when evaluated in this manner, the difference in basement membrane width between normal and prediabetic subjects remains highly significant (equalized for weight, 1083 A + 28 vs. 1373 A +44 [P < 0.01]; equalized for weight/height, 1064 A +41 vs. 1369 A + 45 [P < 0.01] ).
Comparison of capillary basement membrane thickening in deltoid, quadriceps, and gastrocnemnius. While all biopsies used in this study were obtained from a relatively restricted site in the quadriceps muscle, a limited study of basement membrane width in two other muscle groups was carried out to determine whether capillary basement membrane thickening is detectable in other muscles of the diabetic patient. The data in Table XV indicate that both in normal and in diabetic subjects there tends to be a progressive increase in basement membrane width from deltoid to quadriceps to gastrocnemius muscles. It should, however, be emphasized that when compared to capillary basement membrane widths at comparable sites, basement membrane thickening is apparent in the diabetic subject regardless of the biopsy site chosen. These data also indicate, however, that basement membrane widths based on measurements from one group of muscles cannot be directly applied to muscle capillaries obtained at other sites.
Capillary basement membrane width in adipose tissue of diabetic patients. During the procedure employed to obtain muscle biopsies, it is relatively simple to biopsy subcutaneous adipose tissue as well. A comparison of basement membrane widths of such adipose capillaries in a small series of patients (Table XVI) demonstrates that these capillaries have basement membranes that are not statistically different in thickness from those of underlying muscle. While adipose tissue biopsies may therefore be utilized to determine basement membrane hypertrophy in diabetes, the lesser frequency with which capillaries are found in sections of adipose tissue makes this tissue far less practical than muscle for this purpose.
Capillary basement membranes in the kidneys Table XVII demonstrate that there is no correlation between the width of renal capillary basement membranes and that of muscle, and, in fact, despite severe hypertrophy of the renal capillary basement membrane, in only one of the patients with the nephrotic syndrome was some thickening of the muscle capillary' basement membrane noted.
It is therefore apparent that the renal capillary basement membrane hypertrophy that is characteristic of the nephrotic syndrome does not affect muscle capillaries; and it follows that thickening of the muscle capillary basement membrane is a more specific lesion of diabetes mellitus than are the proliferative changes of renal glomerulus, which, while characteristic of diabetes mellitus, are also observed in numerous other conditions.
Insulin levels in prediabetic patients. As demonstrated in Fig. 10 , in the 27 out of 30 prediabetic patients in whom both glucose tolerance tests and insulin concentrations were determined, serum insulin levels did not differ significantly (33) .
1992 from those of the 15 normal subjects studied. Moreover, when insulin/glucose ratios were calculated, no decrease in insulin response was observed at any interval during the glucose tolerance test. It is apparent therefore that, at least as indicated by this type of challenge, the prediabetic patients studied demonstrated no abnormalities of insulin secretion.
DISCUSSION
The primary objective of the present study of basement membrane width of muscle capillaries was twofold: first, to determine whether thickening of the capillary basement membranes is a consistent lesion in patients with overt diabetes mellitus, and second, to evaluate the possibility that such basement membrane thickening may precede and be independent of the carbohydrate abnormalities of the diabetic syndrome.
There have appeared four previous electron microscopic studies that have employed quantitative methods in attempts to demonstrate basement membrane thickening in the muscle capillaries of diabetic patients. The number of patients in each case has been small, and the results have been contradictory. Zacks, Pegues, and Elliott (12), confirming the older light microscopic studies of Goldenberg, Alex, Joshi, and Blumenthal (11) , were able to demonstrate that of five diabetic patients studied, four showed detectable basement membrane thickening of the muscle capillaries. Bloodworth has reported thickening of the basement membrane of muscle capillaries in two diabetic patients (7), and most recently, Fuchs studied three patients with diabetes and reported thickening of the muscle capillary basement membrane in each (13) . Except for the study by Fuchs, neither the sites of the muscle biopsies nor the methods of quantitation of basement membrane width were reported in these earlier studies. Bencosme, West, Kerr, and Wilson (14), while not reporting quantitative data, state that basement membrane thickening of muscle capillaries was found in the capillaries of 12 of 16 diabetic patients studied, and in 3 of 19 nondiabetic subjects. More recently, Vracko and Strandness (18) have seriously criticized these earlier reports of thickened muscle capillary basement membranes in diabetic patients. Utilizing a well-described method for measuring basement membrane area, these investigators have examined capillaries of abdominal muscle obtained at surgery, and report that, in contrast to earlier studies, they were unable to detect hypertrophy of capillary basement membrane in diabetic patients. It should, however, be noted that these conclusions are based on studies of a total of only four overtly diabetic patients; moreover, one of these subjects showed an average basement membrane width that was probably significantly thickened. The reason for the failure of Vracko and Strandness to detect more consistent basement membrane thickening in the abdominal muscle capillaries of their four diabetic subjects is not apparent.
In contrast to previous studies, the present investigation has employed a simple needle biopsy technique, which when coupled with a standardized and reproducible method of quantitating the width of basement membranes, has made it possible to determine basement membrane thickness reliably on over 1500 normal, diabetic, and prediabetic capillaries in a total of 131 patients. This quantitative approach has furthermore permitted detection of a more subtle thickening of basement membrane than has been possible with smaller numbers of samples or less rigorous quantitation.
The results of this study have demonstrated that capillary basement membrane width of diabetic muscle averages over twice that of a normal nondiabetic population. Moreover, it is clear that basement membrane thickening is a remarkably constant finding in diabetic subjects, being present in 98%,o of the 51 diabetic patients examined. By contrast, basement membrane thickening was observed in only 8% of nondiabetic subjects.
These presumably false positive results may represent in part the approximately 2-6% of the general population, who are estimated to be genetically prediabetic; or on the other hand, this result may simply indicate that the criterion employed overestimates the incidence of significant basement membrane thickening by approximately 8%o. Indeed, even with the relatively close agreement between duplicate measurements, the data in Table II illustrate that in the case of borderline values occasionally one sample may show basement membrane widths greater than 1325 A, whereas its duplicate may be within normal range.
The advantages of utilizing muscle as the tisMuscle Capillary Basement Membranes sue in which to study diabetic microangiopathy is well illustrated by the report of Friederici, Tucker, and Schwartz (19) , that thickening of capillary basement membranes cannot be objectively demonstrated in skin biopsies even in overtly diabetic patients. As we have previously noted (1, 34) , changes in the dermal capillaries of diabetics, while subjectively apparent, are difficult to quantitate objectively due to the normal fragmentation and reduplication that characterize the basement membrane of skin capillaries. It is for this reason that, after an unsuccessful preliminary attempt to employ dermal biopsies, we have made use of muscle capillaries as offering a far more reliable means of measuring basement membrane width. In this regard, it should also be noted (Fig. 7) that even in the case of those diabetic patients in whom the average basement membrane width is markedly increased, individual capillaries will have basement membranes that are of normal width. These results demonstrate that even in patients with long-standing diabetes, diabetic microangiopathy need not involve all muscle capillaries; but in addition, this observation further serves to emphasize the need for rigorous adherence to a quantitative procedure of basement membrane measurement that is both "blind" and uses large numbers of electron micrographs taken at random and unselected for quality. The quantification of basement membrane width has also made possible an examination of the possible relationship of the degree of basement membrane thickening to several factors that might influence microangiopathy in the overtly diabetic patients. As demonstrated in Tables VIII and IX The second question that this study has attempted to answer is whether the characteristic microangiopathy of the diabetic syndrome is secondary to or independent of the carbohydrate manifestations of diabetes. This problem was investigated by first determining whether severe hyperglycemia in the absence of genetic diabetes would produce basement membrane thickening in animals and in man, and secondly, by attempting to determine whether genetically prediabetic patients who have neither hyperglycemia nor an abnormal glucose tolerance test will demonstrate basement membrane hypertrophy.
The results of the former studies (Tables XII,  XIII , and XIV), clearly demonstrate that, in contrast to the almost constant finding of basement membrane hypertrophy in patients with genetic diabetes, hyperglycemia of nondiabetic origin, even though of many years duration, seldom leads to hypertrophy of muscle capillary basement membranes. The low incidence of basement membrane thickening in patients with acquired pancreatitis noted in this study is particularly striking in view of the fact that pancreatitis is known to occur more commonly in patients with genetic diabetes mellitus (38) . This finding therefore provides strong evidence that hyperglycemia per se need not cause basement membrane hypertrophy.
The inability of severe pancreatogenous hyperglycemia to cause thickening of capillary basement membranes leads to the related conclusion that it is highly unlikely that the hyperglycemia of genetic diabetes is the factor in the diabetic syndrome responsible for diabetic vascular disease. It is, of course, conceivable that given the genetic predisposition to the diabetic syndrome, the presence of deranged carbohydrate metabolism might influence the rate of development of diabetic microangiopathy. An obvious argument against even such a secondary role for hyperglycemia in the genesis of diabetic vascular disease is the lack of any correlation in the present study (Table X) between severity of the carbohydrate abnormalities and the degree of microangiopathy within the diabetic population.
In general, previous clinical and experimental studies also support the concept that nondiabetic hyperglycemia does not cause the characteristic vascular lesion of diabetes. Lonergan and Robbins (39) , confirming Bell's earlier study (35) , were unable to find nodular intercapillary glomerulosclerosis in any of the 62 cases of hemochromatosis that they examined. Similarly, on the basis of renal biopsy studies, Kark and Gellman have stated that they have never observed intercapillary glomerulosclerosis in nondiabetic hyperglycemia (40) . The only reports of a significant incidence of glomerular changes in secondary hyperglycemia are those of Becker and Miller (41) (43) have reported the finding of funduscopic lesions in only 2 of a series of 42 patients with hemochromatosis. While the true incidence of retinopathy may have been underestimated in the latter study,7 the occasional case of vascular disease observed in such reports is readily explainable on the basis of an incidence of genetic diabetes mellitus in the general population of approximately 2-6%. Finally, the cirrhosis that accompanies hemochromatosis is itself well known to produce nonspecific basement membrane thickening of renal capillaries (44) .
Consistent with the evidence in man that hyperglycemia is not responsible for diabetic renovascular disease is the observation that in animals, hyperglycemia, either induced or spontaneous, does not result in the small vessel disease observed in human diabetes mellitus. Attempts to produce specific small vessel disease in various animals made hyperglycemic with alloxan (45) , pituitary extract (46) , cortisone (47), or pancreatectomy (46, 48) , have been almost uniformly unsuccessful. The early claims that such vascular lesions have been produced in experimental animals have probably been due to misinterpretation of nonspecific renal changes (49) . Recently, Bloodworth has reported the production of diabetic renal lesions in dogs made hyperglycemic with alloxan or 7 Alexander Marble (personal communication). growth hormone (50) . However, the specificity of this lesion must seriously be questioned in view of the fact that as many as 25%o of his nondiabetic control dogs showed similar glomerular lesions.
It should finally be noted that spontaneous hyperglycemia in rodents has not produced diabetic vascular changes (30) , a finding that is consistent with our inability (Table XIV) to find basement membrane thickening of muscle capillary in the three examples of spontaneous hyperglycemia of rodents examined in the present study.
The observation that severe and prolonged hyperglycemia need not cause basement membrane hypertrophy in nondiabetic subjects raises the critical question of whether this vascular lesion in patients with diabetes mellitus may actually be independent of the characteristic carbohydrate derangement of diabetes. Previous suggestions that the small vessel disease of diabetics may precede obvious hyperglycemia have been based on rather fragmentary evidence. There have appeared occasional individual reports in which clinical vascular disease, either glomerulosclerosis (51, 52) or neuropathy (53) , has apparently preceded overt carbohydrate disturbances. The sole previous study of this question consists of a report by Camerini-Davalos et al. (54) , who examined two renal biopsies from genetically prediabetic subjects. While irregular thickening of the glomerular basement membrane was described in both renal biopsies, interpretation of this finding is difficult since neither control biopsies nor quantitative data were included in the report. Moreover, as noted earlier, proliferative changes in the basement membrane of the glomerular capillaries are quite nonspecific and can be produced by a number of nondiabetic diseases.
In the present study we have approached this problem by quantitating muscle capillary basement membrane width in a series of 30 genetically prediabetic patients. The results clearly demonstrate that the average basement membrane width in such subjects is significantly greater than that of normal subjects. Furthermore, thickening of the capillary basement membrane can be shown to be present in over one-half of genetically prediabetic patients.
This finding, we believe, provides the first definitive evidence that the basement membrane lesion of diabetes mellitus can precede the hyperglycemia of diabetes, and this observation, coupled with the further evidence ( Table IV) that hyperglycemia almost never precedes the characteristic basement membrane thickening of diabetes mellitus, strongly supports the possibility that this vascular derangement represents a distinct lesion which is clearly independent of the carbohydrate abnormalities of diabetes mellitus.
It is noteworthy that, as demonstrated in Table  XV , such capillary basement membrane thickening is demonstrable in every skeletal muscle group examined in this study. Moreover, in contrast to a previous report (7) , this lesion definitely can be shown to involve the capillaries supplying adipose tissue. On the other hand, our findings would indicate that the laying down of the collagenous protein (55-58) responsible for basement membrane thickening must be relatively specific for vascular tissue since, as demonstrated in Fig. 4 a and b , the sarcolemmal basement membrane is completely unaffected in diabetic subjects despite the fact that the adjacent capillary basement membrane a few angstroms away may be massively thickened. Whether this specificity is due to differences in chemical composition of the collagen at these two sites, or due to differences in the localization of the enzymes responsible for deposition or removal of such collagen, remains to be determined.
In drawing the major conclusions of this study, two important assumptions have been made in defining the prediabetic subjects. First, it has been considered most likely that diabetes mellitus is inherited as a simple autosomal recessive trait with a high degree of penetrance, and as a result, the offspring of two diabetic parents should have a high probability of ultimately developing overt diabetes mellitus. The data of Steinberg (59, 60 If the lower figure proves to be correct, it would follow from our data that over 70 rather than 53% of the prediabetic patients studied had thickened basement membranes at the time of biopsy. In other words, were diabetes inherited with variable expressivity, or as a multifactorial trait, the major conclusions of this portion of the study would be strengthened rather than weakened. In this regard, it will obviously be necessary to follow those prediabetic patients who did not have basement membrane thickening when first studied to determine whether they, too, will ultimately develop this vascular lesion before the onset of the gross carbohydrate abnormalities of diabetes.
Second, the possibility clearly exists that despite the normal fasting plasma sugars, normal glucose tolerance tests, and normal serum insulin levels employed to rule out abnormalities of glucose and insulin metabolism in the prediabetic patients, subtle but pathologically significant derangements of carbohydrate metabolism as suggested by Fajans and Conn (66) , and CameriniDavalos (67), or of insulin secretion as proposed by Cerasi and Luft (68),8 may be actually present. It should, however, be noted that the oral glucose tolerance test, especially with the strict criteria employed in this study, greatly overdiagnoses carbohydrate abnormalities (72) ; indeed, over onehalf of normal individuals age 40 yr or more would be excluded from both the "normal" and "prediabetic" groups by the rigid criteria used in this study (73) . Further evidence against a pathologically significant derangement in carbohydrate metabolism being present in the prediabetic group is the observation that the glucose tolerance tests of the prediabetics were not only normal, but moreover, did not differ from those of the normal subjects; and most important, even within the prediabetic group there was no relationship between degree of glucose tolerance and basement membrane thickening (Fig. 9 b) . Finally, it should 8 Two additional studies have suggested that absolute insulin levels may be depressed in prediabetic patients (69) (70) ; however, in both of these studies, patients with abnormal glucose tolerance tests were included in the prediabetic group. By contrast, in the study by Soeldner et al. (71) , in which only prediabetic patients with normal oral glucose tolerance were examined, no abnormality in the absolute level of plasma insulin was observed during the glucose tolerance test, and finally, in the study of Camerini-Davalos (67) , prediabetic patients were found to have an elevation in plasma insulin during a glucose tolerance test. be emphasized that, as shown in Tables XII and  XIII , even marked abnormalities in carbohydrate metabolism with exposure of capillaries to many years of both gross hyperglycemia and insulin deficiency will not cause basement membrane hypertrophy in the absence of genetic diabetes mellitus. Taken together, these findings indicate that subtle abnormalities of insulin secretion or of carbohydrate metabolism, even if ultimately they should be demonstrated to be present in prediabetic patients, are unlikely to be the factors responsible for the basement membrane thickening and hence the microangiopathy of diabetes mellitus.
